# Paperplane Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/paperplane-therapeutics

- Industry: Healthcare
- Headquarters: Granby, Canada
- Website: www.paperplanetherapeutics.com
- Total disclosed funding: $1.5M
- Latest round: Seed (Feb 10, 2025)
- Investors on record: 6

## About

Founded in 2019 by CEO Jean-Simon Fortin and CTO David Paquin, Paperplane Therapeutics develops virtual reality solutions to alleviate pain and anxiety in medical environments, enhancing patient experiences through immersive technology. Paperplane Therapeutics focuses on VR therapeutic solutions that aid pain management and anxiety reduction in healthcare settings. The company is headquartered in Granby, Canada, and has engaged in one significant funding round. It recently raised USD 1.5 mn in February 2025, led by A-Venture Capital, with participation from Anges Québec, Cedars-Sinai Health System, and Investment Quebec. Paperplane Therapeutics specializes in virtual reality (VR) therapeutic solutions designed to manage pain and anxiety in healthcare settings. Their primary offerings include immersive, interactive VR experiences that divert patients' attention during medical procedures, thus minimizing the need for pharmacological interventions such as sedation or general anesthesia. These solutions are particularly beneficial in pediatrics, dentistry, and other areas requiring patient cooperation, such as orthopedics and burn care. The company collaborates with healthcare providers and institutions, including notable partnerships with the Mayo Clinic and CHU Sainte-Justine, to conduct clinical trials and validate the efficacy of their products. Currently, their services are available in North America, with expansions aimed at broader global markets. The revenue model for Paperplane Therapeutics is structured around B2B partnerships with healthcare facilities and practitioners who integrate their VR therapies into clinical practice. Revenue is generated through subscription-based access to their platform, which allows hospitals and clinics to utilize their immersive VR technologies across various departments. Additionally, the company engages in direct transactions with dental professionals who implement their technology to enhance patient experiences during procedures. These transactions are facilitated through contracts that specify pricing and usage terms for their VR therapeutic solutions, which are engineered to enhance patient care and improve clinical outcomes. The pricing structure is tailored to the needs of healthcare providers, ensuring broad accessibility while delivering value through innovative treatment approaches.In February 2025, Paperplane Therapeutics raised USD 1.5 mn in venture funding led by Glen Ventures, with participation from Investment Quebec, CABHI, Cedars-Sinai Health System, Anges Québec, and A-Venture Capital. The company will use the funding to enhance its technology and expand its presence in Europe. Future product launches are being designed to further enhance the therapeutic applications of their VR solutions, while specific strategies for entering European markets are currently in development.

## Funding rounds

- Seed, Feb 10, 2025, $1.5M — Investment Quebec, A-Venture Capital, Anges Québec, Cedars-Sinai Health System, Centre for Aging + Brain Health Innovation, Glen Ventures

## Investors

- Investment Quebec (https://capitalatlas.ai/funds/investment-quebec) — Seed
- A-Venture Capital (https://capitalatlas.ai/funds/a-venture-capital) — Seed
- Anges Québec — Seed
- Cedars-Sinai Health System — Seed
- Centre for Aging + Brain Health Innovation — Seed
- Glen Ventures (https://capitalatlas.ai/funds/glen-ventures) — Seed